Company page
Roivant Sciences Ltd.
Roivant Sciences Ltd. is a public biotechnology company traded under the ticker ROIV in the American market. The company has a market capitalization of approximately $21.6 billion. Roivant focuses on advancing innovative therapies to improve patient outcomes across various diseases.
- Ticker
- ROIV:NASDAQ
- Asset type
- Stock
- Market cap
- $21.61B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD